The standard treatment and monitoring of asthma involves the use of inhaled drugs long and short actions. Mainly used hormone agonists. Major GlaxoSmithKline Plc, which manufactures pharmaceuticals, stated that neingalyatsionnye drugs may also be used for the treatment of this disease. Data are presented edition Reuteres.
The first test proved the effectiveness of the drug mepolizumab compared with placebo. The second stage confirmed the effectiveness. Mepolizumab reduced the number of required oral corticosteroids. Patients had better control of asthma. Press-service of the company shares information: the drug is administered by intravenous or subcutaneous injection. It is necessary to introduce just one dose every four weeks.
A second test was performed by injection under the skin. Soon the company plans to apply for approval of drug and mass production. The main active substance is a monoclonal antibody. These substances are produced by immune cells and help fight allergic reactions, including asthma.